Daniel Dubé

2.1k total citations
29 papers, 1.1k citations indexed

About

Daniel Dubé is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Daniel Dubé has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Organic Chemistry and 10 papers in Pharmacology. Recurrent topics in Daniel Dubé's work include Phosphodiesterase function and regulation (6 papers), Cholinesterase and Neurodegenerative Diseases (5 papers) and Receptor Mechanisms and Signaling (5 papers). Daniel Dubé is often cited by papers focused on Phosphodiesterase function and regulation (6 papers), Cholinesterase and Neurodegenerative Diseases (5 papers) and Receptor Mechanisms and Signaling (5 papers). Daniel Dubé collaborates with scholars based in Canada, United States and Singapore. Daniel Dubé's co-authors include Stephen Hanessian, Antonio Ugolini, Andrew A. Scholte, Richard W. Friesen, Paul J. Hodges, Yves Girard, Denis Riendeau, Christine Brideau, Robert N. Young and Diane Ethier and has published in prestigious journals such as Journal of the American Chemical Society, Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Daniel Dubé

29 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Dubé Canada 17 784 394 213 82 69 29 1.1k
Banavara L. Mylari United States 16 530 0.7× 438 1.1× 142 0.7× 79 1.0× 39 0.6× 31 1.2k
Yong Seo Cho South Korea 22 809 1.0× 578 1.5× 167 0.8× 34 0.4× 73 1.1× 92 1.3k
Raymond Houssin France 22 976 1.2× 782 2.0× 208 1.0× 32 0.4× 72 1.0× 103 1.5k
Jaime A. Valderrama Chile 24 1.3k 1.7× 584 1.5× 163 0.8× 58 0.7× 52 0.8× 128 1.9k
Yagamare Fall Spain 21 827 1.1× 382 1.0× 131 0.6× 64 0.8× 47 0.7× 121 1.4k
Juan C. Estévez Spain 20 1.0k 1.3× 537 1.4× 124 0.6× 75 0.9× 53 0.8× 113 1.2k
Barry S. Selinsky United States 15 265 0.3× 415 1.1× 280 1.3× 73 0.9× 26 0.4× 35 881
Toshiro Konoike Japan 17 772 1.0× 284 0.7× 83 0.4× 59 0.7× 112 1.6× 45 1.0k
Generosa Gómez Spain 19 643 0.8× 345 0.9× 105 0.5× 71 0.9× 34 0.5× 104 1.1k
Michael B. Gravestock United Kingdom 20 774 1.0× 394 1.0× 129 0.6× 47 0.6× 91 1.3× 40 1.1k

Countries citing papers authored by Daniel Dubé

Since Specialization
Citations

This map shows the geographic impact of Daniel Dubé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Dubé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Dubé more than expected).

Fields of papers citing papers by Daniel Dubé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Dubé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Dubé. The network helps show where Daniel Dubé may publish in the future.

Co-authorship network of co-authors of Daniel Dubé

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Dubé. A scholar is included among the top collaborators of Daniel Dubé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Dubé. Daniel Dubé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aspiotis, Renée, Elizabeth Cauchon, Austin Chen, et al.. (2012). 3,4-Diarylpiperidines as potent renin inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(5). 1953–1957. 6 indexed citations
2.
Aspiotis, Renée, Austin Chen, Elizabeth Cauchon, et al.. (2011). The discovery and synthesis of potent zwitterionic inhibitors of renin. Bioorganic & Medicinal Chemistry Letters. 21(8). 2430–2436. 7 indexed citations
3.
Lévesque, Jean-François, Kelly Bleasby, Amandine Chefson, et al.. (2011). Impact of passive permeability and gut efflux transport on the oral bioavailability of novel series of piperidine-based renin inhibitors in rodents. Bioorganic & Medicinal Chemistry Letters. 21(18). 5547–5551. 9 indexed citations
4.
Aspiotis, Renée, Christopher I. Bayly, Austin Chen, et al.. (2010). Identification of a new biaryl scaffold generating potent renin inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(19). 5822–5826. 6 indexed citations
5.
Aspiotis, Renée, Denis Deschênes, Daniel Dubé, et al.. (2010). The discovery and synthesis of highly potent subtype selective phosphodiesterase 4D inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(18). 5502–5505. 19 indexed citations
6.
Chen, Austin, Daniel Dubé, Sébastien Gagné, et al.. (2010). Addressing time-dependent CYP 3A4 inhibition observed in a novel series of substituted amino propanamide renin inhibitors, a case study. Bioorganic & Medicinal Chemistry Letters. 20(17). 5074–5079. 12 indexed citations
7.
Chauret, Nathalie, David Claveau, Stephen H. Day, et al.. (2009). Alkyl-bridged substituted 8-arylquinolines as highly potent PDE IV inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(17). 5266–5269. 2 indexed citations
8.
Bateman, Kevin P., Laird A. Trimble, Nathalie Chauret, et al.. (2006). Interspecies in vitro metabolism of the phosphodiesterase‐4 (PDE4) inhibitor L‐454,560. Journal of Mass Spectrometry. 41(6). 771–780. 12 indexed citations
9.
Deschênes, Denis, Daniel Dubé, Michel Gallant, et al.. (2006). Nitrogen-bridged substituted 8-arylquinolines as potent PDE IV inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(10). 2608–2612. 3 indexed citations
10.
Liu, Susana, Alain Veilleux, Lei Zhang, et al.. (2005). Dynamic Activation of Cystic Fibrosis Transmembrane Conductance Regulator by Type 3 and Type 4D Phosphodiesterase Inhibitors. Journal of Pharmacology and Experimental Therapeutics. 314(2). 846–854. 50 indexed citations
11.
Ducharme, Yves, Richard W. Friesen, Marc Blouin, et al.. (2003). Substituted 2-Pyridinemethanol derivatives as potent and selective phosphodiesterase-4 inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(11). 1923–1926. 12 indexed citations
12.
Dubé, Daniel, Christine Brideau, Denis Deschênes, et al.. (1999). 2-Heterosubstituted-3-(4-methylsulfonyl)phenyl-5-trifluoromethyl pyridines as selective and orally active cyclooxygenase-2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 9(12). 1715–1720. 22 indexed citations
13.
Dubé, Daniel & Andrew A. Scholte. (1999). Reductive N-alkylation of amides, carbamates and ureas. Tetrahedron Letters. 40(12). 2295–2298. 90 indexed citations
14.
Dubé, Daniel, Marc Blouin, Christine Brideau, et al.. (1998). Quinolines as potent 5-lipoxygenase inhibitors: Synthesis and biological profile of L-746,530. Bioorganic & Medicinal Chemistry Letters. 8(10). 1255–1260. 244 indexed citations
15.
Friesen, Richard W., Christine Brideau, Chi Chung Chan, et al.. (1998). 2-Pyridinyl-3-(4-methylsulfonyl)phenylpyridines: Selective and orally active cyclooxygenase-2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 8(19). 2777–2782. 111 indexed citations
16.
Delorme, Daniel, Yves Ducharme, Christine Brideau, et al.. (1996). Dioxabicyclooctanyl Naphthalenenitriles as Nonredox 5-Lipoxygenase Inhibitors:  Structure−Activity Relationship Study Directed toward the Improvement of Metabolic Stability. Journal of Medicinal Chemistry. 39(20). 3951–3970. 51 indexed citations
17.
Ducharme, Yves, Christine Brideau, Daniel Dubé, et al.. (1994). Naphthalenic Lignan Lactones as Selective, Nonredox 5-Lipoxygenase Inhibitors. Synthesis and Biological Activity of (Methoxyalkyl)thiazole and Methoxytetrahydropyran Hybrids. Journal of Medicinal Chemistry. 37(4). 512–518. 31 indexed citations
18.
Hanessian, Stephen, et al.. (1987). Progress in natural product chemistry by the chiron and related approaches - synthesis of avermectin B1a. Pure and Applied Chemistry. 59(3). 299–316. 46 indexed citations
19.
Hanessian, Stephen, et al.. (1986). Synthesis of (+)-avermectin B1a. Journal of the American Chemical Society. 108(10). 2776–2778. 68 indexed citations
20.
Hanessian, Stephen, et al.. (1984). Facile access to (S)-1,2,4-butanetriol and its derivatives. Canadian Journal of Chemistry. 62(11). 2146–2147. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Banavara L. Mylari Breakdown of academic impact, for papers by Yong Seo Cho Breakdown of academic impact, for papers by Raymond Houssin Breakdown of academic impact, for papers by Jaime A. Valderrama Breakdown of academic impact, for papers by Yagamare Fall Breakdown of academic impact, for papers by Juan C. Estévez Breakdown of academic impact, for papers by Barry S. Selinsky Breakdown of academic impact, for papers by Toshiro Konoike Breakdown of academic impact, for papers by Generosa Gómez Breakdown of academic impact, for papers by Michael B. Gravestock
Rankless by CCL
2026